These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Targeted therapies used sequentially in metastatic renal cell cancer: overall results from a large experience. Procopio G; Verzoni E; Iacovelli R; Guadalupi V; Gelsomino F; Buzzoni R Expert Rev Anticancer Ther; 2011 Nov; 11(11):1631-40. PubMed ID: 22050012 [TBL] [Abstract][Full Text] [Related]
28. Understanding the importance of smart drugs in renal cell carcinoma. Patard JJ; Rioux-Leclercq N; Fergelot P Eur Urol; 2006 Apr; 49(4):633-43. PubMed ID: 16481093 [TBL] [Abstract][Full Text] [Related]
29. Vaccine therapy in patients with renal cell carcinoma. Van Poppel H; Joniau S; Van Gool SW Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522 [TBL] [Abstract][Full Text] [Related]
30. Building on a foundation of VEGF and mTOR targeted agents in renal cell carcinoma. Flaherty KT; Puzanov I Biochem Pharmacol; 2010 Sep; 80(5):638-46. PubMed ID: 20382128 [TBL] [Abstract][Full Text] [Related]
31. Impact of anti-angiogenic treatments on metastatic renal cell carcinoma. Ainsworth NL; Lee JS; Eisen T Expert Rev Anticancer Ther; 2009 Dec; 9(12):1793-805. PubMed ID: 19954291 [TBL] [Abstract][Full Text] [Related]
32. The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma. Choueiri TK; Bukowski RM; Rini BI Semin Oncol; 2006 Oct; 33(5):596-606. PubMed ID: 17045089 [TBL] [Abstract][Full Text] [Related]
33. Renal cell cancer. Hutson TE; Figlin RA Cancer J; 2007; 13(5):282-6. PubMed ID: 17921725 [TBL] [Abstract][Full Text] [Related]
34. Targeted approaches for treating advanced clear cell renal carcinoma. van Spronsen DJ; De Mulder PH Onkologie; 2006 Sep; 29(8-9):394-402. PubMed ID: 16974118 [TBL] [Abstract][Full Text] [Related]
36. A survey of therapy for advanced renal cell carcinoma. Basso M; Cassano A; Barone C Urol Oncol; 2010; 28(2):121-33. PubMed ID: 19576800 [TBL] [Abstract][Full Text] [Related]
37. Advanced renal cell carcinoma: current and emerging management strategies. Escudier B Drugs; 2007; 67(9):1257-64. PubMed ID: 17547470 [TBL] [Abstract][Full Text] [Related]
38. New systemic treatment options for metastatic renal-cell carcinoma in the era of targeted therapies. Tan TH; Pranavan G; Haxhimolla HZ; Yip D Asia Pac J Clin Oncol; 2010 Mar; 6(1):5-18. PubMed ID: 20398033 [TBL] [Abstract][Full Text] [Related]
39. Targeted therapy for metastatic renal cell carcinoma: a home run or a work in progress? Rini BI; Bukowski RM Oncology (Williston Park); 2008 Apr; 22(4):388-96; discussion 396, 402-3, 476 passim. PubMed ID: 18472614 [TBL] [Abstract][Full Text] [Related]
40. [Second-line treatment of advanced renal cell carcinoma after first-line targeted therapy]. Tomita Y Gan To Kagaku Ryoho; 2011 Jun; 38(6):907-10. PubMed ID: 21677480 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]